-
Mashup Score: 1Resistant/Refractory Cytomegalovirus (CMV) in Transplantation : Clinical Decision Support Tool - 1 year(s) ago
About this Tool This clinical decision support tool (CDST) is designed to assist clinicians in selecting cytomegalovirus (CMV) therapy for solid organ transplant (SOT) patients (lung, heart, liver, kidney, pancreas, or intestine) or hematopoietic cell transplant (HCT) patients 12 years or older with suspected or confirmed antiviral resistant or refractory CMV infection or disease. The definitions…
Source: via.juxlyapps.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Resistant/Refractory Cytomegalovirus (CMV) in Transplantation : Clinical Decision Support Tool - 1 year(s) ago
About this Tool This clinical decision support tool (CDST) is designed to assist clinicians in selecting cytomegalovirus (CMV) therapy for solid organ transplant (SOT) patients (lung, heart, liver, kidney, pancreas, or intestine) or hematopoietic cell transplant (HCT) patients 12 years or older with suspected or confirmed antiviral resistant or refractory CMV infection or disease. The definitions…
Source: via.juxlyapps.comCategories: Latest Headlines, TransplantationTweet
-
Mashup Score: 9
The American Gastroenterological Association has Officially Endorsed this Clinical Decision Support Tool.The American Gastroenterological Association has Officially Endorsed this Clinical Decision Support Tool.The IBD Clinical Decision Support Tool was developed by Parambir Dulai, MD in conjunction with the US Health Outcomes Consortium, a collaboration of leading IBD centers across the US.This…
Source: via.juxlyapps.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 0Resistant/Refractory Cytomegalovirus (CMV) in Transplantation : Clinical Decision Support Tool - 2 year(s) ago
About this Tool This clinical decision support tool (CDST) is designed to assist clinicians in selecting cytomegalovirus (CMV) therapy for solid organ transplant (SOT) patients (lung, heart, liver, kidney, pancreas, or intestine) or hematopoietic cell transplant (HCT) patients 12 years or older with suspected or confirmed antiviral resistant or refractory CMV infection or disease. The definitions…
Source: via.juxlyapps.comCategories: Latest Headlines, TransplantationTweet
-
Mashup Score: 1Resistant/Refractory Cytomegalovirus (CMV) in Transplantation : Clinical Decision Support Tool - 2 year(s) ago
About this Tool This clinical decision support tool (CDST) is designed to assist clinicians in selecting cytomegalovirus (CMV) therapy for solid organ transplant (SOT) patients (lung, heart, liver, kidney, pancreas, or intestine) or hematopoietic cell transplant (HCT) patients 12 years or older with suspected or confirmed antiviral resistant or refractory CMV infection or disease. The definitions…
Source: via.juxlyapps.comCategories: Latest Headlines, TransplantationTweet
RT @RMEIMedEd: @ChemalyRoy now discussing CDST for Resistant/Refractory #CMV in Transplantation https://t.co/7ntF1AQiFt at #EBMT23 #RMEI…